Morepen Laboratories Limited, a leading manufacturer of high-quality APIs, Home Diagnostics, Formulations and OTC products, has approved an incoming investment of Rs. 433 crore in the Extra-Ordinary General Meeting (EGM) of the company. The members approved the issue and allotment of 58.50 million equity shares for cash to Corinth Investment Holdings AG, Switzerland Rs.41.60 per…
The Board of Directors of Morepen Laboratories Limited approved the investment proposed by Corinth Group (Corinth), a global private investment Group headquartered in Switzerland, ‘to the extent of USD 32.50 million in the parent company, Morepen Laboratories Limited (“Morepen” or “The Company”), out of a total USD 100 million investment in the promoter group, subject…
Morepen Laboratories Ltd. has received the ISO-13485 certification from BSI (British Standards Institution, U.K.) for its State of-the-art medical devices manufacturing facility at Baddi (Himachal Pradesh). The certification has been awarded for the manufacturing, distribution and after sales service of all point-of-care diagnostic medical devices and their accessories manufactured at the company’s facility in Baddi.…